Gini Fleming to Class I Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications Gini Fleming has written about Class I Phosphatidylinositol 3-Kinases.
Connection Strength
0.132
-
Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Apr; 141(1):43-8.
Score: 0.132